{
    "clinical_study": {
        "@rank": "88871", 
        "arm_group": [
            {
                "arm_group_label": "Groupe A", 
                "arm_group_type": "Experimental", 
                "description": "Infected by the HIV  Innocents of antiretroviral treatment, with a viral plasmatique load > 1000 copies / ml"
            }, 
            {
                "arm_group_label": "group B", 
                "arm_group_type": "Experimental", 
                "description": "Infected by the HIV  whith antiretroviral treatment for at least 6 months,, with a viral plasmatique load > 40 copies / ml"
            }, 
            {
                "arm_group_label": "group C", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Healthy volunteers"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the investigators study is to demonstrate in healthy subjects and a cohort of\n      patients infected with HIV, the presence of miRNAs in circulating peripheral blood\n      microparticles (MPs)."
        }, 
        "brief_title": "Microparticles, Vector of Genetic Information During HIV Infection", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "HIV,", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age of 40 +/-10 years\n\n          -  Seronegativity for the HIV 2\n\n          -  Patients of the group A: seropositivity for the HIV 1 confirmed in ELISA and Western\n             Blot for at least 2 years and having never received from antiretroviral treatment,\n             with a viral plasmatique load > 1000 copies / ml\n\n          -  Patients of the group B: seropositivity for the HIV 1 confirmed in ELISA and Western\n             Blot for at least 2 years and under stable antiretroviral treatment for at least 6\n             months, with a viral load undetectable plasmatique (< 40 copies / ml)\n\n          -  patients of the group C : Matching on the age (+/-3 years) to a patient\n\n          -  Be considered healthy by the Investigator after a clinical examination Seronegativity\n             for the HIV 1 confirmed in ELISA the day of the taking\n\n        Exclusion Criteria:\n\n        group A et B\n\n          -  Age of < 30 years and > in 50 years\n\n          -  Seropositivity for the HIV 2\n\n        group C Seropositivity for the HIV 2\n\n        -   Be under medicinal treatment"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 31, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01687452", 
            "org_study_id": "2011-A00015-36", 
            "secondary_id": "2010-25"
        }, 
        "intervention": {
            "arm_group_label": [
                "Groupe A", 
                "group B", 
                "group C"
            ], 
            "intervention_name": "Blood samples", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 18, 2012", 
        "location": {
            "contact": {
                "email": "patrice.roll@ap-hm.fr", 
                "last_name": "patrice ROLL"
            }, 
            "facility": {
                "address": {
                    "city": "Marseille", 
                    "country": "France", 
                    "zip": "13354"
                }, 
                "name": "Assistance Publique Hopitaux de Marseille"
            }, 
            "investigator": {
                "last_name": "patrice ROLL", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "3", 
        "official_title": "Microparticles, Vector of Genetic Information During HIV Infection ?", 
        "overall_contact": {
            "email": "patrice.roll@ap-hm.fr", 
            "last_name": "patrice ROLL"
        }, 
        "overall_official": {
            "affiliation": "Assistance Publique h\u00f4pitaux de Marseille", 
            "last_name": "BERNARD BELAIGUES", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "NUMBER OF miRNAs", 
            "safety_issue": "No", 
            "time_frame": "2 YEARS"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01687452"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Demonstrate the presence of miRNAs in microparticles", 
            "safety_issue": "No", 
            "time_frame": "2 YEARS"
        }, 
        "source": "Assistance Publique Hopitaux De Marseille", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique Hopitaux De Marseille", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}